Table 2 IVF/ICSI outcomes of individuals with GDF9 bi-allelic variants
| Â | P1-1 | P1-2 | P2 | |||
|---|---|---|---|---|---|---|
Gn starting dose (IU) | 150 | 225 | 300 | |||
Days of Gn stimulation | 25 | 13 | 24 | |||
Total Gn dosage (IU) | 6300 | 2925 | 8025 | |||
E2 level on the day of hCG injection (pg/ml) | 614 | 386 | 1822 | |||
| Â | L-OV | R-OV | L-OV | R-OV | L-OV | R-OV |
Number of follicles at hCG injection | ||||||
 da ≥18 | 0 | 0 | 0 | 0 | 0 | 1 |
 15 ≤ d <18 | 0 | 0 | 0 | 0 | 2 | 2 |
 10 ≤ d <15 | 1 | 3 | 2 | 1 | 3 | 0 |
 5 ≤ d <10 | 2 | 1 | 6 | 4 | 8 | 8 |
Retrieved oocytes | 0 | 3 | 3 | 2 | 8 | 1 |
Fertilization method | / | ICSI | IVF | |||
Fertilization rate (2PN) | / | 2/5 | 8/9 | |||
High-quality embryo rate (D3) | / | 2/2 | 3/8 | |||